Business
2020 Interim Results
2020 Interim Results.
About this update from Xaar Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5055A\n Xaar PLC\n 30 September 2020\n \n \n \n \n \n \n \n XAAR plc \n \n \n \n \n \n 2020 INTERIM RESULTS \n \n \n \n \n \n BUSINESS ON TRACK WITH CLEAR STRATEGY TO DELIVER LONG-TERM GROWTH\n \n \n \n \n \n \n \n \n Xaar plc (\"Xaar\", the \"Group\" or the \"Company\"), the leading inkjet printing technology group, today announces its interim results for the six months ended 30 June 2020.\n \n \n \n \n \n Summary of results for the six months ended the 30 June 2020:\n \n \n \n \n \n \n \n \n \n \n \n \n 2020\n \n \n \n \n 20194\n \n \n \n \n \n \n Continuing Operations\n \n \n \n \n \n \n \n \n \n \n \n \n Revenue\n \n \n \n \n £23.7m\n \n \n \n \n £25.5m\n \n \n \n \n \n \n Gross profit\n \n \n \n \n £6.4m\n \n \n \n \n £7.0m\n \n \n \n \n \n \n Gross margin %\n \n \n \n \n 27%\n \n \n \n \n 27%\n \n \n \n \n \n \n Gross R&D investment1\n \n \n \n \n £4.0m\n \n \n \n \n £2.7m\n \n \n \n \n \n \n Net R&D investment1\n \n \n \n \n £4.2m\n \n \n \n \n £1.6m\n \n \n \n \n \n \n Adjusted loss before tax2\n \n \n \n \n (£3.9m)\n \n \n \n \n (£2.5m)\n \n \n \n \n \n \n Loss before tax\n \n \n \n \n (£1.1m)\n \n \n \n \n (£2.9m)\n \n \n \n \n \n \n Loss for the year\n \n \n \n \n (£1.6m)\n \n \n \n \n (£2.5m)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Total Operations\n \n \n \n \n \n \n \n \n \n \n \n \n Loss before tax\n \n \n \n \n (£4.4m)\n \n \n \n \n (£52.7m)\n \n \n \n \n \n \n Loss for the year\n \n \n \n \n (£4.8m)\n \n \n \n \n (£50.2m)\n \n \n \n \n \n \n Diluted earnings per share\n \n \n \n \n (4.6p)\n \n \n \n \n (65.0p)\n \n \n \n \n \n \n Net cash at the period end3\n \n \n \n \n £23.9m\n \n \n \n \n £21.6m\n \n \n \n \n \n \n \n \n \n 1 - Net R&D investment excludes the capitalised costs of the High-Speed Sintering development programme\n \n and includes the amortisation cost from December 2019 as required under International Financial Reporting Standards (IAS 38)\n \n \n 2 - Excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, research and development expenditure credit, restructuring expenses, derivative expenses and discontinued operations as reconciled in note 2 \n \n \n 3 - Net cash at 30 Ju...